Maria E. Mitra

Palermo, 90146, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.

Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.

Journal: Therapeutic advances in hematology

Published: August 17, 2022

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study.

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study.

Journal: Journal of fungi (Basel, Switzerland)

Published: May 05, 2022

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes.

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes.

Journal: Journal of clinical medicine

Published: January 20, 2022

Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study.

Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study.

Journal: Leukemia & lymphoma

Published: May 07, 2015

Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).

Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).

Journal: Haematologica

Published: February 02, 2015

Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry.

Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry.

Journal: British journal of haematology

Published: January 29, 2015

Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey.

Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey.

Journal: The Journal of antimicrobial chemotherapy

Published: June 21, 2014

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 04, 2013

Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.

Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 08, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026